- Investing Ideas
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Daiichi Sankyo Company
Market Cap: JP¥5.4t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,824.00
7D
-1.5%
1Y
-19.4%
Chugai Pharmaceutical
Market Cap: JP¥15.5t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥9,327.00
7D
-2.7%
1Y
35.5%
Takeda Pharmaceutical
Market Cap: JP¥8.9t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥5,663.00
7D
-0.4%
1Y
27.8%